What's going on in today's session

ADAMIS PHARMACEUTICALS CORP (ADMP)       0.1985   -0.03 (-11.82%)

After market: 0.2051 +0.01 (+3.32%)


News Image
What's going on in today's session11 days ago - Chartmill

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Gainers

TickerChangeComment
MOHO36.04%ECMOHO LTD (NASDAQ:MOHO) rose 36.04% to $0.16 during Wednesday's after hours session. In the last month the share price dropped with 23.83%.
CPTN24.72%CEPTON INC's (NASDAQ:CPTN) stock price is advancing with 24.72% to a price of $2.22. A press release (Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology) was released earlier today.
FREY19.35%FREYR BATTERY SA's (NYSE:FREY) shares rose 19.35% to $15.68 during Wednesday's session. The stock is trading 29.97% higher than a month ago.
CRH.W14.31%COHN ROBBINS HOLDINGS -CW25's (NYSE:CRH.W) shares rose 14.31% to $0.4 during Wednesday's session. Shareholders saw the stock price going 28.57% lower in the past month.
LRMR12.93%LARIMAR THERAPEUTICS INC's (NASDAQ:LRMR) shares rose 12.93% to $3.63 during Wednesday's session. In the last 3 months the share price increased with 56.59%.
MTP12.77%MIDATECH PHARMA PLC-ADR's (NASDAQ:MTP) stock price increased by 12.77% to $0.53. The stock is trading 35.65% lower than a month ago.
QTEK12.61%QUALTEK SERVICES INC-A's (NASDAQ:QTEK) stock price increased by 12.61% to $1.25. Shareholders saw the stock price going 34.71% lower in the past month.
ALLG12.57%ALLEGO NV (NYSE:ALLG) rose 12.57% to $6.09 during Wednesday's after hours session. In the last 6 months the share price dropped with 71.1%.
STRY12.43%STARRY GROUP HOLDINGS INC-A's (NYSE:STRY) shares rose 12.43% to $2.03 during Wednesday's session. The stock is trading 29.3% lower than a month ago.
MIGI12.26%MAWSON INFRASTRUCTURE GROUP (NASDAQ:MIGI) rose 12.26% to $0.64 during Wednesday's after hours session. Yesterday the company had a press release: Mawson Infrastructure Group Inc Announces August 2022 Operational Update.

For the full top gainers list go to our top gainers screener.

Today's top losers

TickerChangeComment
CBIO-74.23%CATALYST BIOSCIENCES INC's (NASDAQ:CBIO) stock price decreased by 74.23% to $0.5. In the last 3 months the stock gained 28.48%.
PIXY-35.02%SHIFTPIXY INC's (NASDAQ:PIXY) stock price decreased by 35.02% to $13.99. The stock is trading 29.85% lower than 3 months ago.
SESN-34.01%SESEN BIO INC's (NASDAQ:SESN) shares fell 34.01% to $0.44. A press release (SESN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sesen Bio, Inc. Is Fair to Shareholders) was released earlier today.
ADMP-32.63%ADAMIS PHARMACEUTICALS CORP's (NASDAQ:ADMP) shares fell 32.63% to $0.24 during Wednesday's session. In the last 3 months the share price dropped with 20.92%.
BCAN-27.01%BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) shares fell 27.01% to $4.35 during Wednesday's session. In the last month the stock gained 25.04%.
IMTE-25.49%INTEGRATED MEDIA TECHNOLOGY's (NASDAQ:IMTE) stock price decreased by 25.49% to $0.77. Shareholders saw the stock price going 24.26% lower in the past month.
PBTS-24.55%POWERBRIDGE TECHNOLOGIES CO's (NASDAQ:PBTS) stock price decreased by 24.55% to $1.66. Shareholders saw the stock price going 59.46% higher in the past month.
NRBO-22.28%NEUROBO PHARMACEUTICALS INC's (NASDAQ:NRBO) shares fell 22.28% to $16.16. The stock is trading 79.53% higher than a month ago.
TCRT-18.31%ALAUNOS THERAPEUTICS INC's (NASDAQ:TCRT) shares fell 18.31% to $2.08 during Wednesday's session. In the last month the stock gained 55.83%.
MEDS-18.25%TRXADE HEALTH INC's (NASDAQ:MEDS) shares fell 18.25% to $1.11. The stock is trading 40.35% lower than 6 months ago.

For the full top loser list go to our top losers screener.

Back

ADMP Links

ADMP News

News Image11 days ago - Market News VideoWednesday Sector Laggards: Drugs, AirlinesNews Image11 days ago - Adamis Pharmaceuticals CorporationAdamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects

Interim data from the Phase 2/3 clinical trial of Tempol did not demonstrate statistical significance of its primary endpoint of clinical resolution of...

News Image20 days ago - Adamis Pharmaceuticals CorporationAdamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects

The clinical trial of Tempol has reached the initial planned enrollment of 248 subjects Independent Data Monitoring Board to review interim data from...

News Image2 months ago - Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders

Meeting adjourned only with respect to reverse stock split proposal until September 8, 2022...

News Image2 months ago - Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 1:30 p.m. PT / 4:30 p.m. ...

News Image2 months ago - Adamis Pharmaceuticals CorporationAdamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and...

Follow us for more